This study assessed diabetes-related autoantibodies (DMab) in a cohort of 326 diabetes-free patients with rheumatoid arthritis (RA), comprising 260 females and 66 males. Using specific ELISAs, antibodies against glutamic acid decarboxylase (GAD65ab), islet antigen 2 (IA2ab) and zinc transporter 8 (ZnT8ab) were quantified. Production of DM-related antibodies was more frequent in females. Among the DMab-positive cases, ZnT8ab dominated (86%), followed by GAD65ab (26.4%) and IA2ab (7.0%).
The authors report metabolic and inflammatory differences associated with DMab and specifically ZnT8ab positivity. ZnT8ab-positive women had higher circulating insulin and an increased HOMA-IR index, indicating greater insulin resistance. At the same time, these women exhibited lower serum concentrations of several cytokines, including IL-6, IFNγ and IL-9. These associations were observed within the RA cohort free of diagnosed diabetes.
A multivariable logistic regression analysis was used to identify predictors of production of each measured DMab. For ZnT8ab, brain-derived neurotrophic factor (BDNF), insulin levels and disease activity measured by DAS28 emerged as positive predictors of antibody presence. Details of the full model specification, covariates included, effect sizes and confidence intervals were not reported in the source text beyond the stated predictors.
In mixed interaction models, the investigators observed an inverse relationship between increasing ZnT8ab levels and rheumatoid arthritis–related autoantibodies (RAab). The source reports this inverse association but does not provide numerical effect estimates or the specific RA autoantibodies involved in the summary text.
Transcriptomic analyses were integrated with serology. CD14+ cell transcriptomes were examined and the data identified an association between increasing ZnT8ab levels and an activated secretory cell type among CD14+ cells. The study also reports that ZnT8ab levels were directly proportional to ZnT8 production in RA CD4+ T cells, indicating concordance between systemic autoantibody levels and antigen expression in adaptive immune cells. The source indicates these findings were based on publicly available single-cell transcriptome data and additional transcriptional datasets; specific statistical metrics and gene-level details were not provided in the summary.
Single-cell transcriptome profiling of RA synovial tissue identified ZnT8+ cells localized within the synovial lining. These ZnT8-expressing cells were found among lubricin-producing lining layer fibroblasts that the authors describe as programmed for invasive behaviour. This observation links the antigenic target of the prevalent ZnT8 autoantibodies to a cell population within the joint lining, suggesting a potential local source of antigen driving or sustaining the humoral response in RA.
The study was conducted with ethical approvals: the main study approval was granted by the Swedish Ethical Review Authority (Dnr 659-11). Synovium and cartilage sample collection were approved by the local ethics committee of Region West Gotaland (Dnr 2022-01977-02) and Justus Liebig University Giessen (66/08_74/05). All patients provided written informed consent. The authors declare no competing interests.
Transcriptional data supporting the analyses have been deposited in the Gene Expression Omnibus (GEO) with accession codes GSE201669 and GSE201670; individual processed and raw files are indicated as available through the GEO links provided in the source.
Notes on limitations and unreported details
The source summary reports key associations and findings but does not provide certain methodological and quantitative details in the text provided here. Specifically, numerical effect sizes, confidence intervals, p values, the complete regression model specifications, and the identities of the RA autoantibodies included in the inverse association with ZnT8ab were not reported in the source material presented. For full methodological transparency and to evaluate effect magnitude, the original preprint should be consulted for supplementary tables and full methods.